Annual EBIT
-$75.42 M
-$4.51 M-6.36%
31 December 2023
Summary:
Ikena Oncology annual earnings before interest & taxes is currently -$75.42 million, with the most recent change of -$4.51 million (-6.36%) on 31 December 2023. During the last 3 years, it has fallen by -$41.28 million (-120.92%). IKNA annual EBIT is now -307.84% below its all-time high of -$18.25 million.IKNA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$11.60 M
+$3.54 M+23.41%
30 September 2024
Summary:
Ikena Oncology quarterly earnings before interest & taxes is currently -$11.60 million, with the most recent change of +$3.54 million (+23.41%) on 30 September 2024. Over the past year, it has increased by +$10.31 million (+47.07%). IKNA quarterly EBIT is now -515.29% below its all-time high of $2.79 million, reached on 31 December 2021.IKNA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$64.29 M
+$7.91 M+10.95%
30 September 2024
Summary:
Ikena Oncology TTM earnings before interest & taxes is currently -$64.29 million, with the most recent change of +$7.91 million (+10.95%) on 30 September 2024. Over the past year, it has increased by +$11.13 million (+14.76%). IKNA TTM EBIT is now -795.86% below its all-time high of -$7.18 million, reached on 31 March 2020.IKNA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKNA EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +47.1% | +14.8% |
| 3 y3 years | -120.9% | -515.3% | -88.3% |
| 5 y5 years | -307.8% | - | - |
IKNA EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -120.9% | at low | -515.3% | +47.1% | -88.3% | +14.9% |
| 5 y | 5 years | -307.8% | at low | -515.3% | +55.5% | -795.9% | +14.9% |
| alltime | all time | -307.8% | at low | -515.3% | +55.5% | -795.9% | +14.9% |
Ikena Oncology EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$11.60 M(-23.4%) | -$64.29 M(-11.0%) |
| June 2024 | - | -$15.14 M(-3.2%) | -$72.19 M(-4.4%) |
| Mar 2024 | - | -$15.64 M(-28.6%) | -$75.55 M(+0.2%) |
| Dec 2023 | -$75.42 M(+6.4%) | -$21.91 M(+12.3%) | -$75.42 M(+9.9%) |
| Sept 2023 | - | -$19.50 M(+5.5%) | -$68.62 M(+2.4%) |
| June 2023 | - | -$18.49 M(+19.2%) | -$67.00 M(-3.5%) |
| Mar 2023 | - | -$15.52 M(+2.7%) | -$69.46 M(-2.0%) |
| Dec 2022 | -$70.90 M | -$15.11 M(-15.5%) | -$70.90 M(+33.8%) |
| Sept 2022 | - | -$17.88 M(-14.7%) | -$53.00 M(+6.8%) |
| June 2022 | - | -$20.95 M(+23.5%) | -$49.64 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$16.96 M(-707.5%) | -$41.38 M(+21.2%) |
| Dec 2021 | -$34.14 M(-23.3%) | $2.79 M(-119.2%) | -$34.14 M(-45.8%) |
| Sept 2021 | - | -$14.52 M(+14.5%) | -$62.98 M(+15.2%) |
| June 2021 | - | -$12.69 M(+30.5%) | -$54.69 M(+16.2%) |
| Mar 2021 | - | -$9.72 M(-62.7%) | -$47.06 M(+5.7%) |
| Dec 2020 | -$44.52 M(+140.7%) | -$26.05 M(+318.0%) | -$44.52 M(+141.1%) |
| Sept 2020 | - | -$6.23 M(+23.2%) | -$18.47 M(+50.9%) |
| June 2020 | - | -$5.06 M(-29.5%) | -$12.23 M(+70.5%) |
| Mar 2020 | - | -$7.18 M | -$7.18 M |
| Dec 2019 | -$18.49 M | - | - |
FAQ
- What is Ikena Oncology annual earnings before interest & taxes?
- What is the all time high annual EBIT for Ikena Oncology?
- What is Ikena Oncology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Ikena Oncology?
- What is Ikena Oncology quarterly EBIT year-on-year change?
- What is Ikena Oncology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Ikena Oncology?
- What is Ikena Oncology TTM EBIT year-on-year change?
What is Ikena Oncology annual earnings before interest & taxes?
The current annual EBIT of IKNA is -$75.42 M
What is the all time high annual EBIT for Ikena Oncology?
Ikena Oncology all-time high annual earnings before interest & taxes is -$18.25 M
What is Ikena Oncology quarterly earnings before interest & taxes?
The current quarterly EBIT of IKNA is -$11.60 M
What is the all time high quarterly EBIT for Ikena Oncology?
Ikena Oncology all-time high quarterly earnings before interest & taxes is $2.79 M
What is Ikena Oncology quarterly EBIT year-on-year change?
Over the past year, IKNA quarterly earnings before interest & taxes has changed by +$10.31 M (+47.07%)
What is Ikena Oncology TTM earnings before interest & taxes?
The current TTM EBIT of IKNA is -$64.29 M
What is the all time high TTM EBIT for Ikena Oncology?
Ikena Oncology all-time high TTM earnings before interest & taxes is -$7.18 M
What is Ikena Oncology TTM EBIT year-on-year change?
Over the past year, IKNA TTM earnings before interest & taxes has changed by +$11.13 M (+14.76%)